NEW MJ NEWS

Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023

Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, August 7, 2023, at 4:30 p.m. ET to report second quarter 2023 financial results and provide a corporate update.

To participate in the conference call, please register here. Registrants will receive the dial-in numbers and a unique PIN.

A live audio webcast and archived replay of the call will be available under “Events & Presentations” in the Investors section of the Company’s website at www.CaraTherapeutics.com.

About Cara Therapeutics

Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s KORSUVA® (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. The Company is developing an oral formulation of difelikefalin and has Phase 3 programs ongoing for the treatment of pruritus in patients with advanced chronic kidney disease and atopic dermatitis. In addition, the Company has initiated a Phase 2/3 program of oral difelikefalin for the treatment of moderate-to-severe pruritus in patients with notalgia paresthetica. For more information, visit www.CaraTherapeutics.com and follow the company on Twitter, LinkedIn and Instagram.

MEDIA CONTACT:
Annie Spinetta
6 Degrees
973-768-2170
aspinetta@6degreespr.com

INVESTOR CONTACT:
Iris Francesconi, Ph.D.
Cara Therapeutics
203-406-3700
investor@caratherapeutics.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$HEMP Releases Photo of Decorticating Plant in San Francisco Chronicle

Photo Release — Hemp, Inc. and Its Decorticating Plant Featured in San…

Beleave Inc. (BLEVF) Receives Purchase Order for Cannabis 2.0 Products

Beleave Receives Purchase Order for Cannabis 2.0 Products and Provides Other Operational…

The Green Organic Dutchman Holdings Ltd. (TGODF) (TGOD) Enters German CBD Market, Inks Distribution Agreement with Mediakos

TGOD Enters German CBD Market, Inks Distribution Agreement with Mediakos The Green…

Jushi Holdings Inc. (JUSHF) Completes Acquisition of Licensed Cultivator in Ohio

Jushi Holdings Inc. Completes Acquisition of Licensed Cultivator in Ohio Jushi Holdings…